{"filing":{"accession_number":"0001193125-26-275946","cik":"0001162194","ticker":"LAB","company_name":"STANDARD BIOTOOLS INC.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"lab-20260617.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1162194/000119312526275946/lab-20260617.htm"},"events":[{"id":11892,"run_id":10466,"accession_number":"0001193125-26-275946","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Standard Biotools held its Annual Meeting of Stockholders on April 24, 2026, with stockholders voting on five proposals: election of three Class I directors (Michael Egholm, Thomas Carey, and Eli Casdin), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the 2026 Equity Incentive Plan, and approval of an amendment to the 2017 Employee Stock Purchase Plan. All proposals passed with substantial majorities.","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8601,"accession_number":"0001193125-26-275946","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the 2026 Equity Incentive Plan and an amendment to the ESPP increasing reserved shares by 1,200,000. These are compensatory arrangements for officers and employees, directly falling under Item 5.02(e) and the exec_compensation category. The materiality is evident from the substantial share reserve increase and formal stockholder vote approval.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:31:20.499781+00:00","company_name":"","ticker":null,"filing_date":""},{"id":8602,"accession_number":"0001193125-26-275946","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from Standard Biotools' Annual Meeting of Stockholders held on April 24, 2026, covering five proposals: election of Class I directors (Michael Egholm, Thomas Carey, and Eli Casdin), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the 2026 Equity Incentive Plan, and approval of an amendment to the 2017 Employee Stock Purchase Plan. All proposals passed with substantial majorities. This is a routine but material shareholder vote results disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:31:20.499781+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8601,"accession_number":"0001193125-26-275946","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of the 2026 Equity Incentive Plan and an amendment to the ESPP increasing reserved shares by 1,200,000. These are compensatory arrangements for officers and employees, directly falling under Item 5.02(e) and the exec_compensation category. The materiality is evident from the substantial share reserve increase and formal stockholder vote approval.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:31:20.499781+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-18"},{"id":8602,"accession_number":"0001193125-26-275946","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure presents the final voting results from Standard Biotools' Annual Meeting of Stockholders held on April 24, 2026, covering five proposals: election of Class I directors (Michael Egholm, Thomas Carey, and Eli Casdin), advisory approval of executive compensation, ratification of PricewaterhouseCoopers LLP as independent auditor, approval of the 2026 Equity Incentive Plan, and approval of an amendment to the 2017 Employee Stock Purchase Plan. All proposals passed with substantial majorities. This is a routine but material shareholder vote results disclosure required under Item 5.07.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:31:20.499781+00:00","company_name":"STANDARD BIOTOOLS INC.","ticker":"LAB","filing_date":"2026-06-18"}]}